| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0026384> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0026769> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0034862> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0036634> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0039115> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0042213> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C0751324> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C3658241> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C3658242> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C3658243> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C3713756> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5391442> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5398043> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5419859> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5435313> <https://research.tib.eu/covid-19/entity/35158452_HAS_TOPIC_C5544360>
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Brill_Livnat> <https://research.tib.eu/covid-19/entity/Haham_Nitzan> <https://research.tib.eu/covid-19/entity/Levin_Netta> <https://research.tib.eu/covid-19/entity/Rechtman_Ariel> <https://research.tib.eu/covid-19/entity/Rozenberg_Ayal> <https://research.tib.eu/covid-19/entity/Shifrin_Alla> <https://research.tib.eu/covid-19/entity/Vaknin-Dembinsky_Adi> <https://research.tib.eu/covid-19/entity/Zveik_Omri>
?:doi	<https://research.tib.eu/covid-19/entity/S2211-0348%2821%2900610-610.1016/j.msard.2021.103343>
?:doi	S2211-0348(21)00610-610.1016/j.msard.2021.103343
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Multiple sclerosis and related disorders
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35158452>
?:pmid	<https://research.tib.eu/covid-19/entity/35158452>
?:pmid	35158452
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.123
?:rankingScore_hIndex	18
?:title	Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35158452>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35158452>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all